Cardiac Injury - Cardiac Injury - 743 · cardiac-injury
    • CardiologyTalk

      Site: CardiologyTalk

    • Quick Links
      • Schedule An Interview
      • What Is Our Interview Process
    • 0
      • Portuguese
      • Spanish
      • Italian
      • Greek (Greece)
      • Sinhala
      • Polish
      • Arabic (Saudi Arabia)
      • Swedish (Sweden)
      • Portuguese (Brazil)
      • Hindi (India)
      • English (Australia)
      • Hebrew (Israel)
      • Czech
      • Hungarian (Hungary)
      • Chinese
      • Turkish
      • Japanese (Japan)
      • Dutch
      • French
      • German
      • Chinese (Traditional Han, Taiwan)
      • Korean (South Korea)
      • Thai
      • Spanish (Chile)
      • English (United States)
      • Russian
      • Danish (Denmark)
  • Home
  • Trending

  • Login

  • Audio and Video
  • Videos
  • Audio

  • Channels
  • Browse Channels

  • Categories
  • Acute Pulmonary Embolism 1
  • Amyloidosis 10
  • Angina 1
  • Anticoagulation Management 1
  • Aortic Stenosis 1
  • Arrhythmias and Clinical EP 2
  • Atrial Fibrillation 18
  • Autonomic Cardiology 1
  • Blood Pressure 1
  • Cardiac Implantable Electronic Devices 2
  • Cardiac Injury 3
  • Cardiac Surgery 13
  • Cardio-Oncology 17
  • Cardiogenic Shock 4
  • Cardiology 111
  • Cardiology Advocacy 16
  • Cardiomyopathy 5
  • Cardiorenal 2
  • Cardiorenal Syndrome 1
  • Cardiovascular Disease 17
  • Cardiovascular Imaging 2
  • Conference Coverage 63
  • Congenital Heart Disease 1
  • Coronary Artery Disease 11
  • Coronary Microvascular Dysfunction 3
  • Coronary Pharmacotherapy 1
  • Coronary Stent 2
  • COVID-19 81
  • Diabeto-Cardiology 2
  • Dyslipidemia 1
  • Echocardiograms 3
  • Heart Disease 1
  • Heart Failure and Cardiomyopathies 60
  • Heart Transplant 1
  • Heart Valve 3
  • Hemostasis 1
  • Hypertension 12
  • Hypertrophic Cardiomyopathy 2
  • Irregular Heart Rhythm 1
  • Ischemic Heart Disease 4
  • Myocardial Infarction 13
  • Prevention 4
  • Pulmonary Hypertension 2
  • Stroke 1
  • Structural Heart Disease 1
  • TAVR 3
  • Transcatheter Aortic Valve (TAVI) 3
  • Tricuspid Regurgitation 1
  • Valvular Heart Disease 2
  • Vasovagal Syncope 1
  • Ventricular Failure 1
  • Acute Coronary Syndromes 189

  • Install
  • Play a Link
  • About
  • Contact
Marie-Sophie de Koning, MD @MarieSophiedeK1 @CardiologyUmcg @ProfPim #AAC22 ##GIPS-IV Phase II GIPS-IV Trial Marie-Sophie de Koning, MD @MarieSophiedeK1 @CardiologyUmcg @ProfPim #AAC22 ##GIPS-IV Phase II GIPS-IV Trial
0:07:27

Marie-Sophie de Koning, MD @MarieSophiedeK1 @CardiologyUm...

Marie-Sophie de Koning, MD,  PhD Candidate in Cardiology at the UMCG Cardiology Research Institute. In this video, she speaks about AAC 2022 Abstract - Results from the GIPS-IV Trial.

 

Brief Synopsis:

 

The most effective treatment for ST-segment elevation myocardial infarction is now timely and successful reperfusion with primary percutaneous coronary intervention (PPCI) (STEMI). However, persistent myocardial injury caused by ischemia and subsequent reperfusion is seen in the vast majority of patients (88%) and poses a risk of heart failure development. In numerous experimental models, hydrogen sulfide (H2S) administration has been found to protect the heart from "ischemia reperfusion injury." Human data suggests that the H2S-releasing chemical sodium thiosulfate (STS) can be safely administered.

 

The goal of this study was to examine the efficacy and safety of STS versus placebo treatment on myocardial infarct size in STEMI patients treated with PCI.

 

A multicenter, double-blind, randomized controlled clinical trial was used for the study. A total of 380 patients aged 18 and up who were undergoing primary PCI for a first STEMI and deemed amenable by the investigator to be treated with STS 12.5g intravenously (i.v.) or matched placebo immediately after arrival at the catheterization laboratory (cath-lab) and a repeated dose administered 6 hours after the first dose, on top of standard treatment, were included in the study. The primary endpoint is the size of the infarct as determined by cardiac magnetic resonance imaging (CMR-imaging) four months following randomization.

74 Views
11 months Ago
ACC
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Cardiac Injury Description
Cardiac Injury

Podcast Marie-Sophie de Koning, MD @MarieSophiedeK1 @CardiologyUmcg @ProfPim #AAC22 ##GIPS-IV Phase II GIPS-IV Trial
0:07:27
Podcast Marie-Sophie de Koning, MD @MarieSophiedeK1 @Card...
22 Views
11 months Ago
ACC
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Marie-Sophie de Koning, MD @MarieSophiedeK1 @CardiologyUmcg @ProfPim #AAC22 ##GIPS-IV Phase II GIPS-IV Trial Marie-Sophie de Koning, MD @MarieSophiedeK1 @CardiologyUmcg @ProfPim #AAC22 ##GIPS-IV Phase II GIPS-IV Trial
0:07:27
Marie-Sophie de Koning, MD @MarieSophiedeK1 @CardiologyUm...
FHD
74 Views
11 months Ago
ACC
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Ian A. White, MS, PhD #Neobiosis #HeartRegeneration #CardiacInjury #Cardiology #Heart #Research Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury Ian A. White, MS, PhD #Neobiosis #HeartRegeneration #CardiacInjury #Cardiology #Heart #Research Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury
0:11:51
Ian A. White, MS, PhD #Neobiosis #HeartRegeneration #Card...
FHD
103 Views
1 year Ago
Cardiology News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

CardiologyTalk Copyright 2020